Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M.

Gut. 2001 Feb;48(2):251-9.

2.

[Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis].

Bolondi L, Gaiani S, Casali A, Serra C, Piscaglia F.

Radiol Med. 1997 Jul-Aug;94(1-2):4-7. Italian.

PMID:
9424649
3.

Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.

Qian MY, Yuwei J R, Angus P, Schelleman T, Johnson L, Gow P.

J Gastroenterol Hepatol. 2010 May;25(5):951-6. doi: 10.1111/j.1440-1746.2009.06203.x.

PMID:
20546449
4.

Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.

Nouso K, Tanaka H, Uematsu S, Shiraga K, Okamoto R, Onishi H, Nakamura S, Kobayashi Y, Araki Y, Aoki N, Shiratori Y.

J Gastroenterol Hepatol. 2008 Mar;23(3):437-44. Epub 2007 Aug 6.

PMID:
17683496
5.

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.

Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, Jackson S, Ryder S, Price A, Stein K.

Health Technol Assess. 2007 Sep;11(34):1-206. Review.

6.

Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.

Bird TG, Dimitropoulou P, Turner RM, Jenks SJ, Cusack P, Hey S, Blunsum A, Kelly S, Sturgeon C, Hayes PC, Bird SM.

PLoS One. 2016 Jun 16;11(6):e0156801. doi: 10.1371/journal.pone.0156801. eCollection 2016.

7.

Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.

Ungtrakul T, Mahidol C, Chun-On P, Laohapand C, Siripongsakun S, Worakitsitisatorn A, Vidhayakorn S, Boonchuay W, Dechma J, Sornsamdang G, Soonklang K, Sriprayoon T, Tanwandee T, Auewarakul CU.

World J Gastroenterol. 2016 Sep 14;22(34):7806-12. doi: 10.3748/wjg.v22.i34.7806.

8.

Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort.

Paranaguá-Vezozzo DC, Ono SK, Alvarado-Mora MV, Farias AQ, Cunha-Silva M, França JI, Alves VA, Sherman M, Carrilho FJ.

Ann Hepatol. 2014 Jul-Aug;13(4):386-93.

9.

Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.

Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB.

Am J Gastroenterol. 2003 Mar;98(3):679-90.

PMID:
12650806
10.

Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.

Patel D, Terrault NA, Yao FY, Bass NM, Ladabaum U.

Clin Gastroenterol Hepatol. 2005 Jan;3(1):75-84.

PMID:
15645408
11.

Efficacy of a surveillance program for early detection of hepatocellular carcinoma.

Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E.

Cancer. 1996 Sep 1;78(5):977-85.

12.

Hepatocellular carcinoma in liver cirrhosis. A prospective study.

Imberti D, Fornari F, Sbolli G, Buscarini E, Squassante L, Buscarini L.

Scand J Gastroenterol. 1993 Jun;28(6):540-4.

PMID:
7686686
13.

Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?

Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M; Italian Liver Cancer Group.

Am J Gastroenterol. 2007 Nov;102(11):2448-57; quiz 2458. Epub 2007 Jul 7.

PMID:
17617210
14.

Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population.

Cucchetti A, Trevisani F, Cescon M, Ercolani G, Farinati F, Poggio PD, Rapaccini G, Nolfo MA, Benvegnù L, Zoli M, Borzio F, Giannini EG, Caturelli E, Chiaramonte M, Pinna AD; Italian Liver Cancer (ITA.LI.CA) Group.

J Hepatol. 2012 May;56(5):1089-96. doi: 10.1016/j.jhep.2011.11.022. Epub 2012 Jan 13.

PMID:
22245900
15.

Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.

Amarapurkar D, Han KH, Chan HL, Ueno Y; Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma.

J Gastroenterol Hepatol. 2009 Jun;24(6):955-61. doi: 10.1111/j.1440-1746.2009.05805.x. Epub 2009 Mar 11.

PMID:
19383082
16.
17.

Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.

Cho HJ, Kim B, Lee JD, Kang DR, Kim JK, Lee JH, Shin SJ, Lee KM, Yoo BM, Lee KJ, Kim SS, Cheong JY, Cho SW.

Am J Gastroenterol. 2017 Mar;112(3):460-470. doi: 10.1038/ajg.2016.480. Epub 2016 Oct 25.

PMID:
27779194
18.

Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.

Vitale A, Farinati F, Burra P, Trevisani F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Sacco R, Morisco F, Missale G, Foschi FG, Gasbarrini A, Svegliati Baroni G, Virdone R, Chiaramonte M, Spolverato G, Cillo U; Italian Liver Cancer Group.

Liver Transpl. 2015 Oct;21(10):1250-8. doi: 10.1002/lt.24214.

19.

A training program for primary care physicians improves the effectiveness of ultrasound surveillance of hepatocellular carcinoma.

Del Poggio P, Olmi S, Ciccarese F, Mazzoleni M, Jazzetti M, Jamoletti C, Mattiello M, Del Poggio A, Portugali V, Stroffolini T.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1103-8. doi: 10.1097/MEG.0000000000000404.

PMID:
26049705
20.

Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.

Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, Huang GT, Yang PM, Lee HS, Duffy SW.

Int J Cancer. 2002 Mar 10;98(2):257-61.

Supplemental Content

Support Center